Ifast SA
Ifast reported total assets of 437,957 € at the end of the 2025 financial year (annual accounts filed with the NBB on 22 Jun 2026).
The score of Ifast shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -47 % Total assets -44 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Ifast's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −163,234 € | ||||
| Equity | 333,722 € | ||||
| Cash | 235,811 € | ||||
| EBITDA | −50,038 € | ||||
| Total assets | 437,957 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 22 Jun 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 25 Jun 2024
- Year ended 31 Dec 2022filed on 24 May 2023
- Year ended 31 Dec 2021filed on 15 Jun 2022
Ifast's financial analysis
- Solvency76.2%sector median: 60.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Ifast
Ifast's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0842.279.704
- VAT number
- BE0842279704
- Peppol
- Registered · 0208:0842279704 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 30 Dec 2011
- Registered office
- 8800 Roeselare
- Latest accounts
- 2025 · filed on 22 Jun 2026
- Activity
- Research and experimental development on biotechnology (NACE 72101)
Ifast (SA) has been based in Roeselare since 2011, active in: research and experimental development on biotechnology. For 2025, it reports a net loss of 163,234 € and equity of 333,722 €; its revenue is not published. Its solvency stands at 76.2%, above the median of its sector (60.4%).
Companies similar to Ifast
Companies in the same business, of comparable size and area, outside its group.
- Ergotrics Research and experimental development on natural sciences and engineering Turnhout · balance sheet 376,384 €
- Dokter Frank Sierens Research and experimental development on natural sciences and engineering Knokke-Heist · balance sheet 482,826 €
- Orineo Research and experimental development on natural sciences and engineering Kortenberg · balance sheet 394,122 €
- Biocidal Alternative Solutions Research and experimental development on natural sciences and engineering Engis · balance sheet €1.21m
- CannIbite Research and experimental development on natural sciences and engineering Kontich · balance sheet 503,922 €
- Pharmacosmedics Research and experimental development on natural sciences and engineering Knokke-Heist · balance sheet 289,301 €
- Blue3Berg Research and experimental development on natural sciences and engineering Zoersel · balance sheet 803,714 €
- ROKH Other information service activities Etterbeek · balance sheet 623,306 €
Frequently asked questions about Ifast
What is the revenue of Ifast?
Ifast files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Ifast?
In Belgium, the VAT number is the company number prefixed with BE: BE0842279704 for Ifast, if the company is VAT-registered. Its company number (CBE) is 0842.279.704.
Where is the registered office of Ifast?
According to the CBE register, the registered office of Ifast is in 8800 Roeselare.
What is the equity of Ifast?
At the close of the 2025 financial year, the equity of Ifast amounts to 333,722 €, a solvency of 76.2% of total assets.
Who manages Ifast?
The register lists 10 active mandates at Ifast. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Ifast
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →